EXELA Trademark

Trademark Overview

On Tuesday, September 20, 2016, a trademark application was filed for EXELA with the United States Patent and Trademark Office. The USPTO has given the EXELA trademark a serial number of 87177104. The federal status of this trademark filing is REGISTERED as of Tuesday, July 6, 2021. This trademark is owned by Exela Holdings, Inc.. The EXELA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, hepatological, respiratory, hormonal, and psychiatric related diseases and disorders, excluding pharmaceutical preparations and substances that are directly targeted for the treatment of cancer

Product development consulting in the field of developing pharmaceutical products in specialized dosage forms, namely, controlled drug-releasing formulations, sterile products, topical products, and attendant analytical services
exela

General Information

Serial Number87177104
Word MarkEXELA
Filing DateTuesday, September 20, 2016
Status700 - REGISTERED
Status DateTuesday, July 6, 2021
Registration Number6411496
Registration DateTuesday, July 6, 2021
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, February 14, 2017

Trademark Statements

Indication of Colors claimedThe color(s) blue, yellow, orange and white is/are claimed as a feature of the mark.
Description of MarkThe mark consists of the word "EXELA" in blue with the "X" in yellow, orange, blue and white.
Goods and ServicesPharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, hepatological, respiratory, hormonal, and psychiatric related diseases and disorders, excluding pharmaceutical preparations and substances that are directly targeted for the treatment of cancer
Goods and ServicesProduct development consulting in the field of developing pharmaceutical products in specialized dosage forms, namely, controlled drug-releasing formulations, sterile products, topical products, and attendant analytical services

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 26, 2016
Primary Code005
First Use Anywhere DateMonday, November 30, 2015
First Use In Commerce DateMonday, November 30, 2015
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 26, 2016
Primary Code042
First Use Anywhere DateMonday, November 30, 2015
First Use In Commerce DateMonday, November 30, 2015

Trademark Owner History

Party NameExela Holdings, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLenoir, NC 28645
Party NameExela Holdings, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLenoir, NC 28645
Party NameExela Holdings, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLenoir, NC 28645

Trademark Events

Event DateEvent Description
Tuesday, July 6, 2021REGISTERED-PRINCIPAL REGISTER
Thursday, June 3, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, June 2, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, June 1, 2021STATEMENT OF USE PROCESSING COMPLETE
Saturday, May 29, 2021USE AMENDMENT FILED
Saturday, May 29, 2021TEAS STATEMENT OF USE RECEIVED
Thursday, December 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 9, 2020EXTENSION 5 GRANTED
Wednesday, November 25, 2020EXTENSION 5 FILED
Wednesday, December 9, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 25, 2020TEAS EXTENSION RECEIVED
Tuesday, June 2, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 29, 2020EXTENSION 4 GRANTED
Friday, May 29, 2020EXTENSION 4 FILED
Friday, May 29, 2020TEAS EXTENSION RECEIVED
Wednesday, November 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 25, 2019EXTENSION 3 GRANTED
Monday, November 25, 2019EXTENSION 3 FILED
Monday, November 25, 2019TEAS EXTENSION RECEIVED
Saturday, May 25, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 23, 2019EXTENSION 2 GRANTED
Thursday, May 23, 2019EXTENSION 2 FILED
Thursday, May 23, 2019TEAS EXTENSION RECEIVED
Wednesday, November 28, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 26, 2018EXTENSION 1 GRANTED
Monday, November 26, 2018EXTENSION 1 FILED
Monday, November 26, 2018TEAS EXTENSION RECEIVED
Tuesday, May 29, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, April 25, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 19, 2018TTAB RELEASE CASE TO TRADEMARKS
Thursday, April 19, 2018OPPOSITION TERMINATED NO. 999999
Thursday, April 19, 2018OPPOSITION DISMISSED NO. 999999
Monday, August 14, 2017OPPOSITION INSTITUTED NO. 999999
Wednesday, March 29, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 29, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 16, 2017EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, February 14, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 14, 2017PUBLISHED FOR OPPOSITION
Wednesday, January 25, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 9, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, January 6, 2017ASSIGNED TO LIE
Tuesday, December 27, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 27, 2016EXAMINER'S AMENDMENT ENTERED
Tuesday, December 27, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, December 27, 2016EXAMINERS AMENDMENT E-MAILED
Tuesday, December 27, 2016EXAMINERS AMENDMENT -WRITTEN
Tuesday, December 27, 2016ASSIGNED TO EXAMINER
Monday, September 26, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, September 23, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

exela pharmaceutical products treatment preparations substances specialized dosage forms field consulting